Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Small Cell Lung Carcinoma 1 Neoplasm Metastasis 1 Lung Neoplasms 1

Interventions

Paclitaxel 491 Carboplatin 436 Gemcitabine 394 Docetaxel 386 Cisplatin 361 pembrolizumab 344 Bevacizumab 335 Nivolumab 261 Pemetrexed 243 Capecitabine 222 Dexamethasone 213 Fluorouracil 212 Rituximab 203 Trastuzumab 193 Cyclophosphamide 190 Oxaliplatin 161 Erlotinib Hydrochloride 147 Ipilimumab 145 atezolizumab 144 Prednisone 144 Cetuximab 142 Irinotecan 140 Leucovorin 130 Doxorubicin 130 Sorafenib 120 Lenalidomide 119 Bortezomib 118 Sunitinib 107 Everolimus 93 130-nm albumin-bound paclitaxel 92

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Completed × INDUSTRY × SR 48692 × Clear all

NCT00290953 2008-12-23

SESAME

Sanofi

Phase 2/3 Completed

Lung Neoplasms, Neoplasm Metastasis, Small Cell Lung Carcinoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡